Medicare Compliance & Reimbursement - 2014 Issue 19
In other news
Subscribe or sign in to view the full article.
Article Overview
This article summarizes a government settlement involving laboratory billing for urine drug testing and notes concerns raised by federal oversight officials about clinical laboratory claim practices. It is aimed at readers who follow medical coding compliance, laboratory billing, and Medicare/Medicaid oversight. The piece provides a high-level news overview rather than detailed coding guidance, and it centers on the broader compliance and audit context surrounding laboratory services.
Why This Topic Matters
It highlights a compliance enforcement story that may signal increased attention to laboratory billing patterns in Medicare and Medicaid, making it relevant to coders, compliance staff, and laboratory administrators.
What You Will Learn
- Why laboratory billing for urine drug testing drew government attention
- How federal oversight agencies describe fraud, waste, and abuse risk in laboratory services
- The compliance context surrounding Medicare and Medicaid claims for laboratory testing
- Why settlement news may matter to coding and billing professionals
Who Should Read This
- Medical coders
- Laboratory billing staff
- Compliance officers
- Healthcare auditors
- Revenue cycle professionals
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com